Guardant Health

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$265,196
$232,088
$203,471
$201,814
Gross Profit
171,609
150,883
128,748
124,221
EBITDA
-82,238
-88,836
-83,842
-99,191
EBIT
-91,646
-98,878
-94,078
-109,645
Net Income
-92,725
-99,899
-95,159
-111,006
Net Change In Cash
265,196
232,088
203,471
201,814
Free Cash Flow
-45,763
-65,934
-67,148
-83,388
Cash
580,013
629,143
698,572
525,540
Basic Shares
125,304
124,114
123,871
123,754

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$739,016
$563,948
$449,538
$373,653
Gross Profit
449,217
336,896
293,213
250,741
EBITDA
-390,121
-433,305
-614,910
-359,622
EBIT
-432,508
-476,186
-650,872
-381,893
Net Income
-436,373
-479,449
-654,588
-405,670
Net Change In Cash
739,016
563,948
449,538
373,653
Cost of Revenue
-348,740
-338,996
Free Cash Flow
-274,943
-345,461
-386,924
-284,052
Cash
525,540
1,133,537
141,647
492,202
Basic Shares
122,745
111,988
102,178
101,314

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.39
2025-06-30
-$0.44
2025-03-31
-$0.49